A prototype lateral flow assay for detection of orthopoxviruses.
Journal article
Ulaeto DO. et al, (2022), The Lancet. Infectious diseases
Allocated but not treated: the silent 16%
Journal article
Horby P. et al, (2022), LANCET, 399, 1776 - 1776
Allocated but not treated: the silent 16% - Authors' reply.
Other
Horby P. et al, (2022), Lancet (London, England), 399, 1775 - 1776
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years.
Journal article
van Beek J. et al, (2022), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27
Innovations in public health surveillance: updates from a forum convened by the WHO Hub for Pandemic and Epidemic Intelligence, 2 and 3 February 2022.
Journal article
Technical contributors to the Pandemic and Epidemic Intelligence Innovation Forum February meeting and report None., (2022), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.
Journal article
Salam AP. et al, (2022), PLoS neglected tropical diseases, 16
The effect of hand hygiene frequency on reducing acute respiratory infections in the community: a meta-analysis.
Journal article
Mo Y. et al, (2022), Epidemiology and infection, 150
Whole genome sequencing reveals host factors underlying critical Covid-19.
Journal article
Kousathanas A. et al, (2022), Nature
COVID-19 can be called a treatable disease only after we have antivirals.
Journal article
Zhang X. et al, (2022), Science bulletin
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 665 - 676
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Journal article
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 096228022110702 - 096228022110702
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
Journal article
Olayinka AT. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010089 - e0010089
Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health.
Journal article
Gardiner E. et al, (2022), Journal of mental health (Abingdon, England), 1 - 10
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 143 - 151
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Journal article
Fallerini C. et al, (2022), Human genetics, 141, 147 - 173
The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations.
Journal article
Goossens H. et al, (2021), The Lancet. Infectious diseases
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
Journal article
Norris T. et al, (2021), Heart